Eton Pharmaceuticals Inc. (ETON) Misses Q1 EPS by 14c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.05, $0.14 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.3 million versus the consensus estimate of $21.95 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Roblox announces standalone apps, browser play, and creator wallet
• 37 Capital raises $300,000 in partial private placement closing